Effectiveness of Ledipasvir/Sofosbuvir and Sofosbuvir/Velpatasvir in People Who Inject Drugs and/or Those in Opioid Agonist Therapy

We evaluated the effectiveness of ledipasvir/sofosbuvir (LDV/SOF) in treating hepatitis C virus (HCV) genotype 1 and SOF/velpatasvir (SOF/VEL) for all genotypes among people who inject drugs (PWID) and those not injecting drugs and who were on or off opioid agonist therapy (OAT). Study participants...

Descripción completa

Detalles Bibliográficos
Autores principales: Janjua, Naveed Z., Darvishian, Maryam, Wong, Stanley, Yu, Amanda, Rossi, Carmine, Ramji, Alnoor, Yoshida, Eric M., Butt, Zahid A., Samji, Hasina, Chong, Mei, Chapinal, Nuria, Cook, Darrel, Alvarez, Maria, Tyndall, Mark, Krajden, Mel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442698/
https://www.ncbi.nlm.nih.gov/pubmed/30976739
http://dx.doi.org/10.1002/hep4.1307

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442698/
https://www.ncbi.nlm.nih.gov/pubmed/30976739
http://dx.doi.org/10.1002/hep4.1307

Ejemplares similares